Immunological testing plays a key role in transplantation, allowing not only the selection of the most compatible donor but also predicting the risk of rejection, which enables the adjustment of immunosuppressive therapy. This, in turn, helps reduce the frequency of acute and chronic rejections and increases the functioning period of the transplanted kidney.
The establishment of a genetic testing system is of strategic importance for the country's healthcare. It will serve as the foundation for creating a transplantation safety system, which will reduce dependence on foreign laboratories, accelerate clinical decisions, and enhance citizens' trust in domestic medical services that meet international standards.
Furthermore, the NCMD has successfully completed another, the 36th budget operation for kidney transplantation. The recipient is a girl born in 2009 with chronic hemodialysis, who has been undergoing treatment since June 2025. Her mother, born in 1984, served as the donor. The operation was successful, and the condition of both patients is assessed as stable.
Currently, the HLA testing for the donor-recipient pair has been completed at the NCMD laboratory, with results matching those of the reference laboratory. This confirms the high level of quality and reliability of the conducted research. Center specialists emphasize that the implementation of this project will be an important step forward for modern transplantation in Kyrgyzstan and will be carried out on a long-term basis.
